The clinical strategy of implementing interventions designed to actively mitigate or slow the cumulative, age-related decline in function and structure across multiple organ systems. This control is achieved by targeting the fundamental molecular and cellular processes that drive biological aging, such as chronic inflammation, cellular senescence, and telomere shortening. Effective degradation control is essential for extending healthspan and reducing the incidence of age-related disease.
Origin
This term is a clinical adaptation of concepts from gerontology and pathology, where “degradation” refers to the progressive loss of biological fidelity over time. “Systemic” emphasizes the body-wide, interconnected nature of this decline, and “Control” denotes the deliberate, therapeutic effort to manage the rate of this process. It represents a proactive, anti-aging clinical paradigm.
Mechanism
Control mechanisms involve a multifaceted approach, often including the use of senolytics to clear senescent cells, targeted anti-inflammatory agents to reduce chronic low-grade inflammation (inflammaging), and interventions to enhance DNA repair. Hormonally, this involves optimizing the anabolic-to-catabolic balance by maintaining youthful levels of Growth Hormone, DHEA, and testosterone, which are potent drivers of tissue maintenance and repair. The overall effect is a reduction in the rate of molecular damage accumulation and preservation of tissue functional reserve.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.